BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

Daily Return during Q1 2024

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker BIB
  • Intraday Ticker BIB.IV
  • CUSIP 74347R214
  • Inception Date 4/7/10
  • Gross Expense Ratio 1.15%
  • Net Expense Ratio 0.95%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 3/18/2024
  • NAV $55.33
  • NAV Change $-0.74 down caret
  • Market Price $55.39
  • Market Price Change $-0.65 down caret
  • Trading Volume (M) 31,301
  • 30-Day Median Bid Ask Spread 0.21%
  • View Premium / Discount
Snapshot
  • Ticker BIB
  • Intraday Ticker BIB.IV
  • CUSIP 74347R214
  • Inception Date 4/7/10
  • Expense Ratio 0.95%
  • Gross Expense Ratio 1.15%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 3/18/2024
  • NAV $55.33
  • NAV Change $-0.74 down caret
  • Market Price $55.39
  • Market Price Change $-0.65 down caret
  • Trading Volume (M) 31,301
  • 30-Day Median Bid Ask Spread 0.21%
  • View Premium / Discount

The expense ratio above has a contractual waiver ending 9/30/24.

Exposures

Index as of 12/29/2023

Holdings

as of 3/18/2024

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
49.56% -- NASDAQ BIO INDEX SWAP BNP 49,358,929 -- 11,380 --
29.97% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 29,853,911 -- 6,883 --
20.51% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 20,424,534 -- 4,709 --
14.52% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 14,460,692 -- 3,334 --
6.07% GILD GILEAD SCIENCES INC -- $6,046,587.36 82,536 2369174
5.94% REGN REGENERON PHARMACEUTICALS -- $5,912,147.28 6,159 2730190
5.91% AMGN AMGEN INC -- $5,887,198.80 21,732 2023607
5.84% VRTX VERTEX PHARMACEUTICALS INC -- $5,818,558.72 14,144 2931034
5.75% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 5,729,626 -- 1,321 --
4.54% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 4,519,508 -- 1,042 --
3.04% MRNA MODERNA INC -- $3,026,146.50 29,025 BGSXTS3
2.97% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 2,962,403 -- 683 --
2.92% AZN ASTRAZENECA PLC-SPONS ADR -- $2,912,940.60 44,236 2989044
2.43% BIIB BIOGEN INC -- $2,422,834.20 11,043 2455965
1.58% ILMN ILLUMINA INC -- $1,570,919.94 12,071 2613990
1.42% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,410,271.47 9,567 B00FWN1
1.21% BMRN BIOMARIN PHARMACEUTICAL INC -- $1,201,248.73 14,333 2437071
1.07% VTRS VIATRIS INC -- $1,060,940.16 90,216 BMWS3X9
1.06% NBIX NEUROCRINE BIOSCIENCES INC -- $1,054,026.96 7,559 2623911
1.02% RPRX ROYALTY PHARMA PLC- CL A -- $1,019,686.65 33,933 BMVP7Y0
1.00% SNY SANOFI-ADR -- $995,294.47 20,809 2964557
0.98% INCY INCYTE CORP -- $977,991.04 17,056 2471950
0.92% MEDP MEDPACE HOLDINGS INC -- $913,189.12 2,336 BDCBC61
0.89% SRPT SAREPTA THERAPEUTICS INC -- $883,906.10 7,130 B8DPDT7
0.86% ARGX ARGENX SE - ADR -- $855,042.10 2,365 BDVLM39
0.84% UTHR UNITED THERAPEUTICS CORP -- $836,442.75 3,575 2430412
0.69% BNTX BIONTECH SE-ADR -- $684,127.43 7,357 BK6H543
0.64% ASND ASCENDIS PHARMA A/S - ADR -- $641,328.66 4,361 BV9G6B8
0.61% ROIV ROIVANT SCIENCES LTD -- $604,221.66 61,218 BMW4NZ9
0.59% JAZZ JAZZ PHARMACEUTICALS PLC -- $584,469.76 4,736 B4Q5ZN4
0.56% PCVX VAXCYTE INC -- $560,377.44 8,236 BKPVGH6
0.54% EXEL EXELIXIS INC -- $533,674.61 23,033 2576941
0.53% BGNE BEIGENE LTD-ADR -- $530,101.00 3,146 BYYWPW6
0.52% APLS APELLIS PHARMACEUTICALS INC -- $515,341.60 9,160 BYTQ6X1
0.50% CYTK CYTOKINETICS INC -- $498,843.75 7,825 BBBSBJ5
0.48% ITCI INTRA-CELLULAR THERAPIES INC -- $480,730.98 7,354 BHCB0P4
0.47% IONS IONIS PHARMACEUTICALS INC -- $465,356.16 11,072 BDJ0LS6
0.44% CRSP CRISPR THERAPEUTICS AG -- $435,824.06 6,098 BDHF4K6
0.43% MDGL MADRIGAL PHARMACEUTICALS INC -- $427,960.53 1,511 BD59BS7
0.41% BPMC BLUEPRINT MEDICINES CORP -- $403,886.64 4,652 BWY52P3
0.39% LEGN LEGEND BIOTECH CORP-ADR -- $391,386.98 6,053 BMX9K07
0.39% HALO HALOZYME THERAPEUTICS INC -- $388,964.95 9,635 2975098
0.39% RVMD REVOLUTION MEDICINES INC -- $387,090.34 12,511 BL71K91
0.37% BBIO BRIDGEBIO PHARMA INC -- $371,485.98 13,358 BK1KWG8
0.36% KRYS KRYSTAL BIOTECH INC -- $362,339.50 2,150 BD6JX35
0.35% ALKS ALKERMES PLC -- $349,410.76 12,692 B3P6D26
0.35% NUVL NUVALENT INC-A -- $347,901.94 4,454 BMVBZD3
0.34% IMVT IMMUNOVANT INC -- $334,120.26 11,038 BJRFSB7
0.30% IOVA IOVANCE BIOTHERAPEUTICS INC -- $297,688.54 21,218 BF0DMK7
0.30% INSM INSMED INC -- $294,885.34 11,281 2614487
0.29% RARE ULTRAGENYX PHARMACEUTICAL IN -- $291,420.45 6,255 BJ62Z18
0.28% ACLX ARCELLX INC -- $277,200.21 4,011 BPCJ1Q2
0.27% SWTX SPRINGWORKS THERAPEUTICS INC -- $271,498.58 5,606 BGMGM89
0.27% FTRE FORTREA HOLDINGS INC -- $269,030.48 6,746 BRXYZ57
0.27% IBRX IMMUNITYBIO INC -- $265,286.52 50,724 BNSP0B8
0.27% ARWR ARROWHEAD PHARMACEUTICALS IN -- $264,853.68 9,412 BYQBFJ8
0.26% AXSM AXSOME THERAPEUTICS INC -- $261,071.46 3,599 BYZR4X4
0.26% FOLD AMICUS THERAPEUTICS INC -- $259,855.20 22,440 B19FQ48
0.25% IDYA IDEAYA BIOSCIENCES INC -- $246,157.44 5,664 BK0VHF6
0.25% XENE XENON PHARMACEUTICALS INC -- $245,759.70 5,730 BRJ3GY4
0.24% ACAD ACADIA PHARMACEUTICALS INC -- $234,318.24 12,517 2713317
0.22% ARVN ARVINAS INC -- $220,327.20 5,172 BDZ30Q0
0.22% SMMT SUMMIT THERAPEUTICS INC -- $219,358.31 53,307 BMTVQS7
0.21% DNLI DENALI THERAPEUTICS INC -- $212,391.48 10,572 BD2B4V0
0.21% BEAM BEAM THERAPEUTICS INC -- $211,305.20 6,203 BK6L288
0.20% CRNX CRINETICS PHARMACEUTICALS IN -- $200,535.91 5,287 BDD19F8
0.20% NTLA INTELLIA THERAPEUTICS INC -- $199,801.00 7,300 BYZM6C2
0.20% RXRX RECURSION PHARMACEUTICALS-A -- $197,052.10 17,255 BM9FJ13
0.20% MRUS MERUS NV -- $194,875.04 4,397 BZBY005
0.19% RYTM RHYTHM PHARMACEUTICALS INC -- $185,501.40 4,569 BF2YWG4
0.19% APGE APOGEE THERAPEUTICS INC -- $184,868.00 2,825 BM9HHL5
0.18% KYMR KYMERA THERAPEUTICS INC -- $182,562.76 4,643 BMPRZV5
0.18% RCKT ROCKET PHARMACEUTICALS INC -- $182,325.00 6,875 BDFKQ07
0.18% ALPN ALPINE IMMUNE SCIENCES INC -- $176,569.66 4,978 BYX38M1
0.18% KROS KEROS THERAPEUTICS INC -- $174,593.24 2,734 BM7V485
0.17% PTCT PTC THERAPEUTICS INC -- $168,838.20 5,820 B17VCN9
0.17% VERA VERA THERAPEUTICS INC -- $165,382.36 3,988 BL55460
0.16% VCEL VERICEL CORP -- $162,088.92 3,668 BSBMN89
0.16% DYN DYNE THERAPEUTICS INC -- $161,911.08 6,161 BN15WD1
0.16% GH GUARDANT HEALTH INC -- $161,342.70 9,246 BFXC911
0.16% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $158,483.80 2,620 BLCD809
0.16% AMPH AMPHASTAR PHARMACEUTICALS IN -- $156,573.90 3,654 BNFWZS4
0.15% SANA SANA BIOTECHNOLOGY INC -- $149,206.86 16,746 BMFJJ97
0.15% JANX JANUX THERAPEUTICS INC -- $149,185.64 3,844 BMFX8Y7
0.15% TWST TWIST BIOSCIENCE CORP -- $148,581.36 4,392 BGKG6G7
0.15% MYGN MYRIAD GENETICS INC -- $147,668.01 6,827 2614153
0.15% RNA AVIDITY BIOSCIENCES INC -- $144,920.08 6,056 BMWHPY1
0.14% SUPN SUPERNUS PHARMACEUTICALS INC -- $142,162.02 4,158 B72ZBG4
0.14% SNDX SYNDAX PHARMACEUTICALS INC -- $141,493.60 6,455 BN7Q7R7
0.14% ARDX ARDELYX INC -- $138,579.84 17,676 BN89V40
0.14% HRMY HARMONY BIOSCIENCES HOLDINGS -- $136,247.67 4,313 BKSGZN7
0.13% GERN GERON CORP -- $131,708.53 41,483 2370381
0.13% GPCR STRUCTURE THERAPEUTICS INC -- $128,760.00 3,700 BQS9486
0.13% MORF MORPHIC HOLDING INC -- $127,214.92 3,802 BK8M4J4
0.13% PTGX PROTAGONIST THERAPEUTICS INC -- $125,992.42 4,427 BDCBCD8
0.13% INBX INHIBRX INC -- $125,818.94 3,601 BK1MBC3
0.13% AGIO AGIOS PHARMACEUTICALS INC -- $125,039.01 4,269 BCBVTX1
0.12% VCYT VERACYTE INC -- $123,049.16 5,702 BFTWZY0
0.12% KURA KURA ONCOLOGY INC -- $121,695.36 5,784 BYZD465
0.12% IRON DISC MEDICINE INC -- $121,117.36 1,834 BMGJZJ8
0.12% FDMT 4D MOLECULAR THERAPEUTICS IN -- $117,324.43 3,781 BKLXFX5
0.12% DVAX DYNAVAX TECHNOLOGIES CORP -- $116,087.40 9,922 BRJZSK0
0.12% AKRO AKERO THERAPEUTICS INC -- $114,794.68 4,277 BK7Y2V9
0.11% NVCR NOVOCURE LTD -- $112,439.52 8,136 BYSS4X4
0.11% EWTX EDGEWISE THERAPEUTICS INC -- $109,843.69 7,073 BKY5JZ8
0.11% VIR VIR BIOTECHNOLOGY INC -- $109,555.44 10,258 BK4PZ38
0.11% ANIP ANI PHARMACEUTICALS INC -- $108,192.00 1,600 BCDWBX6
0.11% AVDL AVADEL PHARMACEUTICALS-ADR -- $107,504.09 6,817 BDTZ028
0.10% PCRX PACIRA BIOSCIENCES INC -- $103,452.28 3,532 B3X26D8
0.10% XNCR XENCOR INC -- $103,306.75 4,643 BGCYWN8
0.10% ADMA ADMA BIOLOGICS INC -- $102,981.78 17,337 B9NSBM2
0.10% PRTA PROTHENA CORP PLC -- $102,392.29 4,081 B91XRN2
0.10% ABCL ABCELLERA BIOLOGICS INC -- $102,090.78 22,242 BL53SR3
0.10% IRWD IRONWOOD PHARMACEUTICALS INC -- $101,192.41 11,891 B3MZ6K5
0.10% LGND LIGAND PHARMACEUTICALS -- $97,028.30 1,345 2501578
0.10% COLL COLLEGIUM PHARMACEUTICAL INC -- $95,541.80 2,428 BX7RSN3
0.10% MNKD MANNKIND CORP -- $94,908.66 20,543 BF081J4
0.09% GMAB GENMAB A/S -SP ADR -- $94,592.34 3,186 BBC9WC7
0.09% DAWN DAY ONE BIOPHARMACEUTICALS I -- $92,481.27 6,639 BLB0YH0
0.09% MIRM MIRUM PHARMACEUTICALS INC -- $92,021.16 3,542 BJDX8Y8
0.09% DCPH DECIPHERA PHARMACEUTICALS IN -- $91,149.30 6,138 BZ1LFB2
0.09% ETNB 89BIO INC -- $89,208.00 7,080 BK1K484
0.09% SAGE SAGE THERAPEUTICS INC -- $88,443.42 4,566 BP4GNK9
0.08% VERV VERVE THERAPEUTICS INC -- $84,545.12 6,352 BNKGXX2
0.08% VRNA VERONA PHARMA PLC - ADR -- $80,165.86 5,162 BYWPZK5
0.08% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $80,005.96 10,051 BMCWKZ2
0.08% TARS TARSUS PHARMACEUTICALS INC -- $79,555.39 2,599 BMH5RL1
0.08% BCRX BIOCRYST PHARMACEUTICALS INC -- $79,396.20 15,660 2100362
0.08% OCUL OCULAR THERAPEUTIX INC -- $79,041.12 8,373 BNZB1X8
0.08% EYPT EYEPOINT PHARMACEUTICALS INC -- $79,023.00 3,710 BMGS7L1
0.08% TRML TOURMALINE BIO INC -- $77,939.48 1,948 BQ80NC6
0.08% RGNX REGENXBIO INC -- $75,363.75 3,375 BZ0G875
0.08% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $75,268.19 7,354 BKX9VD3
0.08% ORIC ORIC PHARMACEUTICALS INC -- $75,117.56 5,117 BKVDFF7
0.08% RLAY RELAY THERAPEUTICS INC -- $74,737.50 9,965 BN2R582
0.08% ZNTL ZENTALIS PHARMACEUTICALS INC -- $74,705.40 5,390 BMQ5T49
0.08% PACB PACIFIC BIOSCIENCES OF CALIF -- $74,702.85 20,355 B4N8MH9
0.07% MGNX MACROGENICS INC -- $73,507.20 4,712 BFDV8K0
0.07% SRRK SCHOLAR ROCK HOLDING CORP -- $72,336.00 5,480 BFZQ0L8
0.07% INVA INNOVIVA INC -- $69,931.68 4,803 BDDXF67
0.07% ZLAB ZAI LAB LTD-ADR -- $68,035.04 3,763 BD9GVY0
0.07% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $67,253.90 2,030 BKC9SX3
0.07% PLRX PLIANT THERAPEUTICS INC -- $66,824.20 4,577 BMDWW66
0.07% SPRY ARS PHARMACEUTICALS INC -- $66,503.04 7,292 BMCR7V2
0.07% AUTL AUTOLUS THERAPEUTICS PLC -- $66,343.86 10,692 BFMLGR4
0.07% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $65,413.44 2,712 BKDQKM6
0.07% TNGX TANGO THERAPEUTICS INC -- $65,005.72 7,748 BP2P6L0
0.06% PRME PRIME MEDICINE INC -- $62,141.04 8,852 BPBJFM7
0.06% EOLS EVOLUS INC -- $60,774.00 4,341 BDRJH21
0.06% KNSA KINIKSA PHARMACEUTICALS-A -- $59,464.46 3,037 BD0MGM0
0.06% FUSN FUSION PHARMACEUTICALS INC -- $58,530.64 5,501 BJK0NH0
0.06% CABA CABALETTA BIO INC -- $58,524.90 3,255 BK5MWR1
0.06% ZYME ZYMEWORKS INC -- $56,955.78 5,318 BPCQZY9
0.06% SLRN ACELYRIN INC -- $56,342.28 7,394 BQPF874
0.06% GRFS GRIFOLS SA-ADR -- $56,071.40 9,268 B8K7T65
0.06% AUPH AURINIA PHARMACEUTICALS INC -- $55,918.74 10,986 BFWLC09
0.05% NVAX NOVAVAX INC -- $54,648.48 10,632 BJDQXG4
0.05% CVAC CUREVAC NV -- $54,605.31 17,011 BN4RD42
0.05% ALLO ALLOGENE THERAPEUTICS INC -- $53,628.88 12,784 BFZNYB7
0.05% COGT COGENT BIOSCIENCES INC -- $53,205.56 7,894 BLR6XK8
0.05% WVE WAVE LIFE SCIENCES LTD -- $52,572.24 9,272 BYZG9R0
0.05% GLPG GALAPAGOS NV-SPON ADR -- $50,081.59 1,499 B292NQ7
0.05% CGEM CULLINAN ONCOLOGY INC -- $49,790.00 3,250 BM90J52
0.05% SVRA SAVARA INC -- $48,423.51 10,281 BYXGN81
0.05% EDIT EDITAS MEDICINE INC -- $47,979.80 6,215 BZ8FPH3
0.05% NRIX NURIX THERAPEUTICS INC -- $47,687.76 3,714 BMVLGP2
0.05% FULC FULCRUM THERAPEUTICS INC -- $47,614.60 4,705 BJDX8Z9
0.05% ANAB ANAPTYSBIO INC -- $46,780.23 2,019 BDRW1L7
0.05% LXRX LEXICON PHARMACEUTICALS INC -- $46,715.76 18,538 BWFZX59
0.05% OLMA OLEMA PHARMACEUTICALS INC -- $46,369.80 4,185 BMZ4LN0
0.05% YMAB Y-MABS THERAPEUTICS INC -- $45,752.00 3,325 BG31GH0
0.05% OABI OMNIAB INC -- $45,739.40 8,830 BN13S71
0.05% CNTA CENTESSA PHARMACEUTICALS-ADR -- $45,485.46 4,283 BLB0YQ9
0.04% ALEC ALECTOR INC -- $43,644.00 7,274 BJ4LDC4
0.04% SIGA SIGA TECHNOLOGIES INC -- $42,937.95 5,401 2107437
0.04% BMEA BIOMEA FUSION INC -- $42,770.45 2,713 BNKF6N0
0.04% TVTX TRAVERE THERAPEUTICS INC -- $41,507.58 5,781 BLFGJD5
0.04% ALXO ALX ONCOLOGY HOLDINGS INC -- $41,434.80 3,784 BLN7XQ1
0.04% HCM HUTCHMED CHINA-ADR -- $40,375.41 2,357 BYXV9H7
0.04% LYEL LYELL IMMUNOPHARMA INC -- $40,150.24 19,303 BN6MB18
0.04% ELVN ENLIVEN THERAPEUTICS INC -- $39,575.84 3,131 BMFD115
0.04% CSTL CASTLE BIOSCIENCES INC -- $39,500.33 2,085 BKLCWZ3
0.04% MLYS MINERALYS THERAPEUTICS INC -- $39,368.42 3,122 BP9N0G0
0.04% REPL REPLIMUNE GROUP INC -- $38,609.64 4,663 BDDVW37
0.04% KALV KALVISTA PHARMACEUTICALS INC -- $37,864.42 3,158 BD06CS0
0.04% VYGR VOYAGER THERAPEUTICS INC -- $37,496.25 4,125 BY7RB53
0.04% MRNS MARINUS PHARMACEUTICALS INC -- $37,387.90 4,145 BM8MVZ3
0.04% PHAT PHATHOM PHARMACEUTICALS INC -- $36,009.72 4,349 BJLKVS6
0.04% VTYX VENTYX BIOSCIENCES INC -- $35,917.98 4,501 BMG99Y1
0.04% CRBU CARIBOU BIOSCIENCES INC -- $35,101.55 6,718 BNYJR68
0.04% ADPT ADAPTIVE BIOTECHNOLOGIES -- $35,053.14 11,023 BJ5FZ74
0.03% PETQ PETIQ INC -- $34,512.08 2,218 BDH65C8
0.03% URGN UROGEN PHARMA LTD -- $33,988.00 2,344 BZ7PJQ1
0.03% RVNC REVANCE THERAPEUTICS INC -- $33,107.88 6,702 BJFSR99
0.03% MXCT MAXCYTE INC -- $32,809.56 7,868 BKMQF66
0.03% TBPH THERAVANCE BIOPHARMA INC -- $32,722.95 3,783 BMNDK09
0.03% ABUS ARBUTUS BIOPHARMA CORP -- $32,359.60 12,740 BZ0QMB7
0.03% TSHA TAYSHA GENE THERAPIES INC -- $30,252.39 14,203 BNC1BX1
0.03% AVXL ANAVEX LIFE SCIENCES CORP -- $30,067.16 6,238 BYTYP72
0.03% MGTX MEIRAGTX HOLDINGS PLC -- $29,958.40 4,832 BFYQFJ2
0.03% TERN TERNS PHARMACEUTICALS INC -- $28,562.99 4,694 BMDJ0C9
0.03% HROW HARROW INC -- $27,987.32 2,668 BHNDW86
0.03% ITOS ITEOS THERAPEUTICS INC -- $27,896.94 2,719 BMWXFT4
0.03% THRD THIRD HARMONIC BIO INC -- $27,685.98 3,066 BNNPQY8
0.03% HUMA HUMACYTE INC -- $27,616.68 7,868 BMYTJP4
0.03% PGEN PRECIGEN INC -- $26,283.51 18,909 BKM5C84
0.03% ACIU AC IMMUNE SA -- $26,267.50 7,505 BZC0D70
0.03% AVIR ATEA PHARMACEUTICALS INC -- $25,576.00 6,394 BLN9Z50
0.02% NAUT NAUTILUS BIOTECHNOLOGY INC -- $24,897.86 9,503 BNG1NK8
0.02% AMRN AMARIN CORP PLC -ADR -- $24,534.14 29,312 2301938
0.02% ERAS ERASCA INC -- $23,527.85 11,477 BNLYBF3
0.02% EXAI EXSCIENTIA PLC -- $23,382.70 3,665 BP48134
0.02% XERS XERIS BIOPHARMA HOLDINGS INC -- $22,350.09 10,493 BLR7H87
0.02% RAPT RAPT THERAPEUTICS INC -- $21,766.29 2,613 BK5T6R0
0.02% ATAI ATAI LIFE SCIENCES NV -- $21,060.37 12,611 BN6M8F1
0.02% BLUE BLUEBIRD BIO INC -- $20,823.84 14,461 BBFL7S1
0.02% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $19,281.60 1,545 BL95N25
0.02% CHRS COHERUS BIOSCIENCES INC -- $18,781.20 8,460 BRK0149
0.02% QURE UNIQURE NV -- $18,060.98 3,634 BJFSR88
0.02% VNDA VANDA PHARMACEUTICALS INC -- $16,391.25 4,371 B12W3P6
0.01% AMLX AMYLYX PHARMACEUTICALS INC -- $14,726.14 5,149 BPCK358
0.01% OVID OVID THERAPEUTICS INC -- $14,657.37 5,369 BYPFK63
0.01% -- ACHILLION PHARMACEUTICALS INC - CVR -- $11,641.22 25,307 --
0.01% ME 23ANDME HOLDING CO -CLASS A -- $11,284.18 23,963 BM9CKX3
0.01% ACRS ACLARIS THERAPEUTICS INC -- $6,196.20 5,388 BYV2W40
-- RPHM RENEO PHARMACEUTICALS INC -- $4,150.84 2,531 BMHR7T5
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- -- TREASURY BILL -- $14,696,696.85 15,000,000 BRYQ9Y9
-- -- NET OTHER ASSETS (LIABILITIES) -- $13,001,039.86 13,001,040 --

Index

as of 12/29/2023

  • Total Number of Companies225
  • Price/Earnings Ratio--
  • Price/Book Ratio4.289
  • Dividend Yield ( % )0.79
  • Avg. Index Market Capitalization$6.63 billion
About the Index

The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.